APPLICATION
ANDA065284
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-30
LATEST ACTION
2018-04-09
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
CEFPROZILDiscontinued
CEFPROZIL 250MG/5ML · FOR SUSPENSION · ORAL
CEFPROZILDiscontinued
CEFPROZIL 125MG/5ML · FOR SUSPENSION · ORAL
Approval history
2018-04-09Labeling · Supplement 12 · standardAP
2008-06-03Labeling · Supplement 4AP
2006-05-30Labeling · Supplement 1AP
2005-12-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.